Two Sigma Securities’s Filana Therapeutics FLNA Stock Holding History

Two Sigma Securities’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.5K	Buy	+12,696	New	+$26.1K	﹤0.01%	1364
2025 Q2	–	Sell	-17,694	Closed	-$26.5K	–	2004
2025 Q1	$26.5K	Buy	+17,694	New	+$44.7K	﹤0.01%	1064
2019 Q2	–	Sell	-10,558	Closed	-$14K	–	2374
2019 Q1	$14K	Buy	+10,558	New	+$12.1K	﹤0.01%	1701
2017 Q3	–	Sell	-10,587	Closed	-$44K	–	1182
2017 Q2	$44K	Buy	10,587 +1,793	+20%	+$8.46K	0.01%	730
2017 Q1	$55K	Buy	8,794 +3,804	+76%	+$17.3K	0.01%	797
2016 Q4	$20K	Sell	4,990 -180	-3%	-$835	0.01%	652
2016 Q3	$36K	Buy	+5,170	New	+$85.7K	0.01%	575

Other funds holding FLNA

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Securities's FLNA Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Filana Therapeutics (FLNA) in Q1 2026: 12,696 shares worth $21.5K. The stake represents ﹤0.01% of the portfolio and ranks #1364 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in FLNA as recently as Q1 2025.

Two Sigma Securities first reported a position in FLNA in Q3 2016 and has held it in 7 quarters since. The position peaked at $55K in Q1 2017. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

Two Sigma Securities held 12,696 shares of Filana Therapeutics worth $21.5K as of Q1 2026.
Filana Therapeutics was a new Two Sigma Securities position in Q1 2026.
Filana Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1364 holding.
Two Sigma Securities first reported a position in Filana Therapeutics in Q3 2016 and has held it in 7 quarters since.
Two Sigma Securities's Filana Therapeutics position peaked at $55K in Q1 2017.
101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.